Venetoclax, azacitidine, combined with low-dose cytarabine in treatment-naive, elderly or unfit patients with acute myeloid leukemia

Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2022
This article has no abstract
Epistemonikos ID: 03be137d3ab59c7b7906d04d88c815686d630ae4
First added on: Apr 08, 2025